There have been many studies evaluating endovascular therapy in the management of ischemic stroke published in the past few years. This post will serve as a review of those studies.
R.E.B.E.L. EM – Endovascular Therapy for Acute Ischemic Stroke Read More »
Which patients need what type of scanning? Where should that scanning be done – at the stroke center or at the peripheral center? Which patients should get systemic thrombolytics? Which patients should get endovascular therapy? In this EM Cases main episode podcast, a follow up to our episode on TIA released in November 2018 with Walter Himmel and David Dushenski, we try to simplify the confusing time-based and brain tissue-based options for stroke management…
EM Cases: ED Stroke Management in the Age of Endovascular Therapy Read More »
A stroke mimic is defined as a nonvascular disease that presents with stroke-like symptoms, often indistinguishable from an actual stroke. Why does it matter if a mimic is diagnosed as a stroke? Learn the pearls and pitfalls of stroke mimics.
Stroke Mimics: Pearls and Pitfalls Read More »
Every few years, we come to a crossroads that makes us reexamine our current clinical practice and consider a better intervention. For the past twenty years, patients presenting with acute ischemic stroke have had essentially one option for therapy: intravenous thrombolytics. Since the NINDS-2 trial in 1995 [1], tPA has erupted onto the scene of stroke management and has become the gold standard despite ongoing questions behind the true efficacy of tPA.
Endovascular Stroke Therapy: Is This the New Standard? Read More »